These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
625 related articles for article (PubMed ID: 16328478)
41. Semi-quantitative study of calcitonin gene methylation in myelodysplastic syndrome. Wu S; Xie G; Bai R; Wang Y; Zhu P Chin Med J (Engl); 1998 Aug; 111(8):690-3. PubMed ID: 11245020 [TBL] [Abstract][Full Text] [Related]
43. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas. Weber MM; Fottner C; Liu SB; Jung MC; Engelhardt D; Baretton GB Cancer; 2002 Nov; 95(10):2086-95. PubMed ID: 12412161 [TBL] [Abstract][Full Text] [Related]
44. [Expression of cell cycle control genes in myelodysplastic syndromes]. Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Cao YR; Wang XL; Tu MF Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):10-4. PubMed ID: 15946501 [TBL] [Abstract][Full Text] [Related]
45. Expression of P2X7 in human hematopoietic cell lines and leukemia patients. Zhang XJ; Zheng GG; Ma XT; Yang YH; Li G; Rao Q; Nie K; Wu KF Leuk Res; 2004 Dec; 28(12):1313-22. PubMed ID: 15475073 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes. Buccisano F; Maurillo L; Tamburini A; Del Poeta G; Del Principe MI; Ammatuna E; Consalvo MI; Campagna S; Ottaviani L; Sarlo C; Renzi D; Faccia S; Fraboni D; Lo Coco F; Amadori S; Venditti A Eur J Haematol; 2008 Feb; 80(2):107-14. PubMed ID: 18028430 [TBL] [Abstract][Full Text] [Related]
47. Expression of the anti-apoptotic gene survivin in myelodysplastic syndrome. Badran A; Yoshida A; Wano Y; Mutoh M; Imamura S; Yamashita T; Tsutani H; Inuzuka M; Ueda T Int J Oncol; 2003 Jan; 22(1):59-64. PubMed ID: 12469185 [TBL] [Abstract][Full Text] [Related]
48. Increased expression of APAF-1 in low-risk myelodysplastic syndrome: a possible role in the pathophysiology of myelodysplasia. Benites BD; Traina F; Duarte Ada S; Lorand-Metze IG; Costa FF; Saad ST Eur J Haematol; 2010 Jun; 84(6):525-30. PubMed ID: 20345447 [TBL] [Abstract][Full Text] [Related]
49. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups. Gadji M; Adebayo Awe J; Rodrigues P; Kumar R; Houston DS; Klewes L; Dièye TN; Rego EM; Passetto RF; de Oliveira FM; Mai S Clin Cancer Res; 2012 Jun; 18(12):3293-304. PubMed ID: 22539801 [TBL] [Abstract][Full Text] [Related]
50. Overexpression of the Doppel protein in acute myeloid leukaemias and myelodysplastic syndromes. Travaglino E; Comincini S; Benatti C; Azzalin A; Nano R; Rosti V; Ferretti L; Invernizzi R Br J Haematol; 2005 Mar; 128(6):877-84. PubMed ID: 15755294 [TBL] [Abstract][Full Text] [Related]
52. Comparative analysis of G-CSFR and GM-CSFR expressions on CD34+ cells in patients with aplastic anemia and myelodysplastic syndrome. Xu H; Li A; Yu Y; Li J; Liu X; Wang X; Wang X; Xu G Int J Lab Hematol; 2009 Dec; 31(6):597-602. PubMed ID: 18637807 [TBL] [Abstract][Full Text] [Related]
53. The relative extent and propensity of CD34+ vs. CD34- cells to undergo apoptosis in myelodysplastic marrows. Mundle S; Venugopal P; Shetty V; Ali A; Chopra H; Handa H; Rose S; Mativi BY; Gregory SA; Preisler HD; Raza A Int J Hematol; 1999 Apr; 69(3):152-9. PubMed ID: 10222652 [TBL] [Abstract][Full Text] [Related]
54. Limited numbers of apoptotic cells in fresh paraffin embedded bone marrow samples of patients with myelodysplastic syndrome. Brada SJ; van de Loosdrecht AA; Koudstaal J; de Wolf JT; Vellenga E Leuk Res; 2004 Sep; 28(9):921-5. PubMed ID: 15234568 [TBL] [Abstract][Full Text] [Related]
55. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes. Maratheftis CI; Andreakos E; Moutsopoulos HM; Voulgarelis M Clin Cancer Res; 2007 Feb; 13(4):1154-60. PubMed ID: 17317824 [TBL] [Abstract][Full Text] [Related]
56. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations. Harada Y; Harada H J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039 [TBL] [Abstract][Full Text] [Related]
57. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms. Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775 [TBL] [Abstract][Full Text] [Related]
58. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia. Suárez L; Vidriales B; García-Laraña J; López A; Martínez R; Martín-Reina V; Tormo M; González-San Miguel JD; Lavilla E; García-Boyero R; Orfao A; San Miguel JF; Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321 [TBL] [Abstract][Full Text] [Related]
59. Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome. Qian J; Chen Z; Wang W; Cen J; Xue Y Oncol Rep; 2005 Nov; 14(5):1189-97. PubMed ID: 16211284 [TBL] [Abstract][Full Text] [Related]
60. Accelerated cellular senescence in myelodysplastic syndrome. Wang YY; Cen JN; He J; Shen HJ; Liu DD; Yao L; Qi XF; Chen ZX Exp Hematol; 2009 Nov; 37(11):1310-7. PubMed ID: 19748549 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]